Latest news with #MohanKeshavamurthy


Hans India
20-05-2025
- Health
- Hans India
Hospital plans centre of education for South Asia
Bengaluru: Fortis Hospitals in Bengaluru signed a Memorandum of Understanding on Monday with Teleflex Incorporated, a global provider of medical technologies, to create UroLift Center of Education for South Asia in India. The UroLift System uses a minimally invasive approach to treating Benign Prostatic Hyperplasia (BPH), stated a press release issued by Fortis Hospitals on Monday. Typically, no catheter is required after the treatment, according to Fortis Hospitals. BPH is a common condition marked by urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life, added the press release. 'Our collaboration with Fortis Hospitals will empower medical professionals with advanced knowledge and hands-on training, ultimately improving patient care,' said Arun Kaushik, Managing Director, South Asia, Teleflex. Dr. Mohan Keshavamurthy, Principal Director of Renal Sciences, Fortis Hospitals in Bengaluru, said, 'Through this collaboration, we are committed to helping Urologists acquire requisite skill to optimise individualised treatment solutions for patients requiring Endoscopic surgical solutions for BPH.' These training programs for the UroLift System will be conducted at Fortis Hospitals, Bannerghatta Road, Bengaluru, he added.

The Hindu
19-05-2025
- Business
- The Hindu
City hospital signs MoU with Teleflex to create a UroLift Center of Education for South Asia
Fortis Hospitals, Bengaluru, recently signed a Memorandum of Understanding (MoU) with Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies to create UroLift Center of Education for South Asia in India. The UroLiftTM System uses a minimally invasive approach to treating Benign Prostatic Hyperplasia (BPH). BPH is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life. 'The UroLiftTM System is a BPH procedure that does not require heating, cutting, removal, or destruction of prostate tissue. The UroLiftTM System provides rapid symptom relief and preserves sexual function. Typically, no catheter is required after the treatment,' said the press release. 'Our collaboration with Fortis Hospitals will empower medical professionals with advanced knowledge and hands-on training, ultimately improving patient care,' said Arun Kaushik, Managing Director, South Asia, Teleflex. Dr. Mohan Keshavamurthy, Principal Director – Renal Sciences, Fortis Hospitals, Bengaluru, said, 'Through this collaboration, we are committed to helping Urologists acquire requisite skill to optimise individualised treatment solutions such as UROLIFT for patients requiring Endoscopic surgical solutions for BPH and enhancing outcomes thereof. The programme is designed to provide a comprehensive training program to Urologists to ensure careful selection and safe delivery of the UroLift System to patients in their practice.'